Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Nanomedicine. 2016 Nov 25;13(3):1183–1193. doi: 10.1016/j.nano.2016.11.015

Figure 4. In vitro delivery of doxorubicin by Endo28-3WJ-Sph1 nanoparticles to cells.

Figure 4

Both annexin A2 positive SKOV3 and annexin A2 negative HEK293T cells were tested. Nanoparticles harboring doxorubicin conjugated with scramble aptamer sequences were tested as negative controls. The cells were treated with nanoparticles for (a) 8 hrs or (b) 2hrs, and imaged. The doxorubicin channel is shown as red; cell nuclei stained with DAPI is shown as blue.